Metabolomics Profiles of Hepatocellular Carcinoma in a Korean Prospective Cohort: The Korean Cancer Prevention Study-II
Open Access
- 30 April 2018
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 11 (5) , 303-312
Abstract
In the prospective Korean Cancer Prevention Study-II (KCPS-II), we investigated the application of metabolomics to differentiate subjects with incident hepatocellular carcinoma (HCC group) from subjects who remained free of cancer (control group) during a mean follow-up period of 7 years with the aim of identifying valuable metabolic biomarkers for HCC. We used baseline serum samples from 75 subjects with incident HCC and 134 age- and gender-matched cancer-free subjects. Serum metabolic profiles associated with HCC incidence were investigated via metabolomics analysis. Compared with the control group, the HCC group showed significantly higher serum levels of aspartate aminotransferase (AST), alanine aminotransferase, and γ-glutamyl transpeptidase. At baseline, compared with the control group, the HCC group showed significantly higher levels of 9 metabolites, including leucine, 5-hydroxyhexanoic acid, phenylalanine, tyrosine, arachidonic acid, and tauroursodeoxycholic acid (TUDCA), but lower levels of 28 metabolites, including oleamide, androsterone sulfate, L-palmitoylcarnitine, lysophosphatidic acid (LPA) 16:0, LPA 18:1, and lysophosphatidylcholines (lysoPC). Multiple linear regression revealed that the incidence of HCC was associated with the levels of tyrosine, AST, lysoPCs (16:1, 20:3), oleamide, 5-hydroxyhexanoic acid, androsterone sulfate, and TUDCA (adjusted R2 = 0.514, P = 0.036). This study showed the clinical relevance of the dysregulation of not only branched amino acids, aromatic amino acids, and lysoPCs but also bile acid biosynthesis and linoleic acid, arachidonic acid, and fatty acid metabolism. In addition, tyrosine, AST, lysoPCs (16:1, 20:3), oleamide, 5-hydroxyhexanoic acid, androsterone sulfate, and TUDCA were identified as independent variables associated with the incidence of HCC. Cancer Prev Res; 11(5); 303–12. ©2018 AACR.Keywords
All Related Versions
Funding Information
- National Research Foundation of Korea (NRF-2012M3A9C4048762)
- Ministry of Health & Welfare, Republic of Korea (HI14C2686010115)
- Ministry of Health & Welfare, Republic of Korea (HI14C2686)
This publication has 40 references indexed in Scilit:
- Pseudotargeted Metabolomics Method and Its Application in Serum Biomarker Discovery for Hepatocellular Carcinoma Based on Ultra High-Performance Liquid Chromatography/Triple Quadrupole Mass SpectrometryAnalytical Chemistry, 2013
- Comprehensive Analysis of Common Serum Liver Enzymes as Prospective Predictors of Hepatocellular Carcinoma in HBV PatientsPLOS ONE, 2012
- LC–MS Based Serum Metabolomics for Identification of Hepatocellular Carcinoma Biomarkers in Egyptian CohortJournal of Proteome Research, 2012
- MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysisNucleic Acids Research, 2012
- Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular CarcinomaMolecular & Cellular Proteomics, 2011
- Cytosolic Phospholipase A2 and Lysophospholipids in Tumor AngiogenesisJNCI: Journal of the National Cancer Institute, 2010
- Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndromeJournal of Lipid Research, 2010
- Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory statusLipids in Health and Disease, 2007
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999